2 Jul 2018 07:00
Omega Diagnostics Group PLC
("Omega" or "the Company")
Announcement of results
Omega (AIM: ODX), the medical diagnostics company, announces that it will release its results for the year ended 31 March 2018 on Monday 6 August 2018.
Further to the disposal of our infectious disease business (excluding VISITECT® CD4), which we announced on 28 June 2018, the extended timeline for releasing results will enable the Company to prioritise its stated objectives.
Contacts:
Omega Diagnostics Group PLC | Tel: 01259 763 030 |
David Evans, Chairman Colin King, Chief Executive | www.omegadiagnostics.com |
Kieron Harbinson, Group Finance Director | |
finnCap Ltd | Tel: 020 7220 0500 |
Geoff Nash/James Thompson (Corporate Finance) | |
Camille Gochez (Corporate Broking) | |
Walbrook PR Limited | Tel: 020 7933 8780 or omega@walbrookpr.com |
Helen Cresswell | Mob: 07841 917 679 |
Paul McManus | Mob: 07980 541 893 |